Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This study will investigate the effectiveness of nanohydroxyapatite (nano-HAP)-containing
toothpastes and cream to relieve dentin hypersensitivity, comparing it with those of a
commercial desensitizing dentifrice containing calcium sodium phosphosilicate (Novamin®
technology) and a standard fluoride dentifrice containing 1,500 ppm fluoride as sodium
monofluorophosphate (MFP).
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio